Literature DB >> 4156582

The effect of ketamine upon depolarizing and non-depolarizing neuromuscular blockade in rabbit.

L G Bogdan, S N Glisson, A A El-Etr.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4156582     DOI： 10.1007/bf00498992

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN： 0028-1298            Impact factor:   3.000


× No keyword cloud information.
  7 in total

1.  An azobis-arylimidazo-pyridinium derivative: a rapidly acting non-depolarising muscle-relaxant. Clinical study.

Authors:  B R Simpson; L Strunin; T M Savege; B Walton; E I Foley; M P Maxwell; L A Ross; D M Harris
Journal:  Lancet       Date:  1972-03-04       Impact factor: 79.321

2.  Current status of ketamine anaesthesia.

Authors:  J G Bovill; D L Coppel; J W Dundee; J Moore
Journal:  Lancet       Date:  1971-06-19       Impact factor: 79.321

3.  Ketamine: myoneural activity and interaction with neuromuscular blocking agents.

Authors:  R Cronnelly; K L Dretchen; M D Sokoll; J P Long
Journal:  Eur J Pharmacol       Date:  1973-04       Impact factor: 4.432

4.  Correlation of psychologic and physiologic observations from children undergoing repeated ketamine anesthesia.

Authors:  R D Wilson; D L Traber; B L Evans
Journal:  Anesth Analg       Date:  1969 Nov-Dec       Impact factor: 5.108

5.  Dissociative anesthesia: further pharmacologic studies and first clinical experience with the phencyclidine derivative CI-581.

Authors:  G Corssen; E F Domino
Journal:  Anesth Analg       Date:  1966 Jan-Feb       Impact factor: 5.108

6.  Short-lasting, competitive neuromuscular blocking activity in a series of azobis-arylimidazo-(1,2-a)-pyridinium dihalides.

Authors:  L Bolger; R T Brittain; D Jack; M R Jackson; L E Martin; J Mills; D Poynter; M B Tyers
Journal:  Nature       Date:  1972-08-11       Impact factor: 49.962

7.  Clinical trial of ketamine (CI-581): a preliminary report.

Authors:  S A Oduntan; R Y Gool
Journal:  Can Anaesth Soc J       Date:  1970-07
  7 in total
  3 in total

1.  Ketamine enhances phase I and phase II neuromuscular block of succinylcholine.

Authors:  S K Tsai; C M Lee; B Tran
Journal:  Can J Anaesth       Date:  1989-03       Impact factor: 5.063

2.  The effect of ketamine upon norepinephrine and dopamine levels in rabbit brain parts.

Authors:  S N Glisson; A A el-Etr; B C Bloor
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976-11       Impact factor: 3.000

3.  Modification by ketamine on the neuromuscular actions of magnesium, vecuronium, pancuronium and alpha-bungarotoxin in the primate.

Authors:  S K Tsai; K T Liao; C M Lee
Journal:  Can J Anaesth       Date:  1992-01       Impact factor: 5.063
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.